IP Library Granted Patent US 8,394,641
Granted Patent B2
US 8,394,641 · App. 13/305,820 · Granted Mar 12, 2013

Method of hydrolyzing an enzymatic substrate

Inventor: Theodore Winger (Morrisville, NC)
Assignee: Advanced Liquid Logic Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,641
App. No.
13/305,820
Granted
Mar 12, 2013
Kind
B2
Abstract

The invention is directed to droplet actuator devices and assay methods. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate within an aqueous environment in contact with an oil.

Claims (17)

1. A method of hydrolyzing an enzymatic substrate, the method comprising:

(a) forming an inclusion complex with the substrate in an aqueous droplet in contact with oil;

(b) hydrolyzing the substrate; and

wherein the substrate is a 4-MU- or HMU containing substrate.

2. The method of claim 1 wherein the inclusion complex is formed using cyclodextrin.

3. The method of claim 1 wherein the cyclodextrin comprises hydroxypropyl-β-cyclodextrin.

4. The method of claim 3 wherein the concentration of hydroxypropyl-β-cyclodextrin comprises from about 5 mM to about 15 mM.

5. The method of claim 3 wherein the concentration of hydroxypropyl-β-cyclodextrin comprises from about 7 mM to about 13 mM.

6. The method of claim 3 wherein the concentration of hydroxypropyl-β-cyclodextrin comprises from about 9 mM to about 11 mM.

7. The method of claim 3 wherein the concentration of hydroxypropyl-β-cyclodextrin comprises from about 9.5 mM to about 11.5 mM.

8. The method of claim 3 wherein the cyclodextrin comprises methyl-β-cyclodextrin.

9. The method of claim 8 wherein the concentration of methyl-β-cyclodextrin comprises from about 1 mM to about 20 mM.

10. The method of claim 8 wherein the concentration of methyl-β-cyclodextrin comprises from about 5 mM to about 15 mM.

11. The method of claim 8 wherein the concentration of methyl-β-cyclodextrin comprises from about 7 mM to about 13 mM.

12. The method of claim 8 wherein the concentration of methyl-β-cyclodextrin comprises from about 9 mM to about 11 mM.

13. The method of claim 8 wherein the concentration of methyl-β-cyclodextrin comprises from about 9.5 mM to about 11.5 mM.

14. The method of claim 1 , wherein the aqueous droplet is surrounded by oil.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 28, 2012
From: ADVANCED LIQUID LOGIC, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027771/0281 →
Continuity (12)
Continuation In Part 12531844 · Feb 26, 2010
Continuation 13012831 · Jan 25, 2011
Provisional Application 61288633 · Dec 21, 2009
Provisional Application 61290296 · Dec 28, 2009
Provisional Application 61325580 · Apr 19, 2010
Provisional Application 61334376 · May 13, 2010
Provisional Application 61359943 · Jun 30, 2010
Provisional Application 61378705 · Aug 31, 2010
Provisional Application 61382564 · Sep 14, 2010
Provisional Application 61392633 · Oct 13, 2010
Provisional Application 61406380 · Oct 25, 2010
Related Publication 20120136147A1 · May 31, 2012